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ABSTRACT
The DEAD-box helicase Ded1 is an essential yeast
protein that is closely related to mammalian DDX3
and to other DEAD-box proteins involved in devel-
opmental and cell cycle regulation. Ded1 is consid-
ered to be a translation-initiation factor that helps
the 40S ribosome scan the mRNA from the 5′ 7-
methylguanosine cap to the AUG start codon. We
used IgG pull-down experiments, mass spectrom-
etry analyses, genetic experiments, sucrose gradi-
ents, in situ localizations and enzymatic assays to
show that Ded1 is a cap-associated protein that ac-
tively shuttles between the cytoplasm and the nu-
cleus. NanoLC-MS/MS analyses of purified com-
plexes show that Ded1 is present in both nuclear
and cytoplasmic mRNPs. Ded1 physically interacts
with purified components of the nuclear CBC and
the cytoplasmic eIF4F complexes, and its enzymatic
activity is stimulated by these factors. In addition,
we show that Ded1 is genetically linked to these fac-
tors. Ded1 comigrates with these proteins on sucrose
gradients, but treatment with rapamycin does not ap-
preciably alter the distribution of Ded1; thus, most of
the Ded1 is in stable mRNP complexes. We conclude
that Ded1 is an mRNP cofactor of the cap complex
that may function to remodel the different mRNPs
and thereby regulate the expression of the mRNAs.
INTRODUCTION
The DEAD-box proteins are an ubiquitous family of pro-
teins that are found in nearly all organisms in all three king-
doms of life. They are implicated in all processes involving
RNA, including transcription, splicing, ribosomal biogen-
esis, RNA export, translation and RNA decay [reviewed by
(1–3)]. DEAD-box proteins belong to the DExD/H super-
family (SF2) of putative RNA andDNAhelicases, and they
are so named because of the amino acid sequence of mo-
tif II (D-E-A-D in single letter representation). The highly
conserved ‘helicase’ core, which is found in all SF2 and SF1
proteins, consists of two, linked, RecA-like domains and se-
quence motifs that are conserved within the different fami-
lies. Individual proteins are distinguished by the presence of
nonconserved amino- and carboxyl-terminal extensions of
highly variable length and by insertions and deletionswithin
the conserved core (4).
The DEAD-box family contains at least nine conserved
motifs that are needed for adenine recognition, and for ATP
and RNA binding. The amino- and carboxyl-terminal ex-
tensions, as well as variability in the conserved motifs, en-
able researchers to classify the proteins into different sub-
families. Motif III links the cooperative binding of the ATP
and RNA ligands, which subsequently promotes the AT-
Pase activity of the protein in association with motifs II
and VI (5). Thus, DEAD-box proteins are ATP-dependent
RNA-binding proteins and RNA-dependent ATPases. In
addition, a number of proteins studied in vitro were shown
to unwind short RNA-RNA and RNA-DNA duplexes, but
generally only at very high protein to substrate ratios. Typ-
ically, the proteins require a single-stranded region to load
on the substrate prior to the displacement reaction, but this
region can be either 5′ or 3′ to the duplex. Hence, most
DEAD-box proteins lack directionality, and subsequently
they are not processive.
These proteins are thought to have a number of cellular
roles, such as helicases to disrupt RNA secondary struc-
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tures, as chaperones to help form functional RNAs and as
RNPases to facilitate the remodeling of ribonucleoprotein
(RNP) complexes. However, the majority of the proteins
that are tested in vitro lack substrate specificity and enzy-
matic regulation. This implies that the specificity and regu-
lation are conferred by protein cofactors in vivo. Indeed, it is
known that the intrinsically poor ATPase activity of Dbp5
(DDX19A), which is needed for messenger RNA (mRNA)
export from the nucleus, is enhanced by Gle1 and phytic
acid (inositol hexakisphosphate or IP6) on the cytoplasmic
side of the nuclear pore [reviewed by (6–8)]. The inherently
poor ATPase and helicase activity of eIF4A is significantly
enhanced by the protein components of the translation-
initiation complex [see (9) and references therein]. In con-
trast, the ATPase activity of the exon junction complex
(EJC) protein eIF4AIII (DDX48) is inhibited by its inter-
actions with MAGOH and Y14, while MLN51 enhances
its affinity for RNA (10). Thus, the cofactors can function
as on and off switches to control the enzymatic activities of
the DEAD-box proteins. In contrast, little is known about
how the substrate specificity is conferred. The exceptions
are some eubacterial proteins that have accessory carboxyl-
terminal domains with affinity for certain RNAs. For ex-
ample, the Escherichia coli protein DbpA and the related
YxiN protein from Bacillus subtilis have secondary bind-
ing sites for helix 92 of ribosomal RNA (rRNA) that are
independent and separable from the helicase core domain
(11). An opposing example is the SrmB protein from E. coli
that has specificity for the 5′ end of 23S rRNA that is inde-
pendent of its carboxyl-terminal domain (12). In this case,
the specificity is at least partially conferred by its interac-
tions with the L4 and L24 ribosomal proteins. Eukaryotic
DEAD-box proteins often contain carboxyl-terminal ex-
tensions that enhance the affinity, in general, for RNAs, but
to date these extensions are not known to confer specificity
to discrete RNA substrates [(4,13) and references therein].
The budding yeast, Saccharomyces cerevisiae, has 25
DEAD-box proteins that are largely essential for the vi-
ability of the organism and that are not interchangeable
[reviewed by (14)]. Many of the proteins are implicated
in the biogenesis of the ribosomes, but the other proteins
are involved in transcription, mRNA processing, RNA ex-
port, translation and RNA decay. Thus, yeast is a practi-
cal model system because the proteins are not redundant,
they are mostly essential, they are represented in all the im-
plicated cellular processes and there are obvious homologs
in metazoans. Moreover, yeast genetics facilitate deletions
of the endogenous gene and its replacement by a plasmid-
encoded variant. Our laboratory has concentrated on study-
ing Ded1, which has one of the highest DEAD-box protein
activities (4).
Ded1was first isolated as an essential domain in the chro-
mosomal region encoding the HIS3 gene [DED1: Defines
Essential Domain1; (15)]. It was later found as an extra-
genic suppressor of a prp8 mutation (16); Prp8 is a com-
ponent of the U4/U6-U5 snRNP complex that is involved
in mRNA splicing. Subsequently, Ded1 was implicated in
the transcription of polymerase III RNAs (17), as a general
translation-initiation factor (18,19), in 40S ribosome scan-
ning (20), in yeast L-A virus replication (21) and finally in
processing body (P-body) formation and RNA degradation
(22). Ded1 is closely related to a subfamily of DEAD-box
proteins that are involved in developmental and cell cycle
regulation [reviewed by (23–26)], including the Drosophila
Vasa protein for which the crystal structure was solved in
the presence of RNA and a nonhydrolyzable analog of ATP
[adenosine 5′-(, -imido)triphosphate (AMP-PNP); (27)].
We used various genetic, physical and enzymatic ap-
proaches to isolate and characterize potential partners of
Ded1, with the objective of better understanding the role(s)
Ded1 plays in the cell, how its enzymatic activity is regulated
and how the substrate specificity is determined. We found
that Ded1 is physically and genetically associated with pro-
tein factors that are found on the 5′ cap structures of both
nuclear and cytoplasmicRNP complexes, and thatDed1 ac-
tively shuttles between the two cellular compartments. We
found that these factors stimulate the RNA-dependent AT-
Pase activity of Ded1, which indicated that the interactions
are functionally important. Finally, we found that Ded1
is associated primarily with stable RNPs that are not ac-
tively engaged in translation. This latter observation sug-
gests thatDed1might function to regulate RNP remodeling
and thereby regulate genetic expression.
MATERIALS AND METHODS
Cloning, strains and molecular manipulations
Manipulations of yeast, including media preparation,
growth conditions, transformation and 5-fluoroorotic acid
(5-FOA) selection, were done according to standard pro-
cedures (28). Molecular manipulations, polymerase chain
reaction (PCR) amplification and cloning were as pre-
viously described (29). We typically used the BY4742
yeast strain (Euroscarf) for the biochemical analyses and
the CW04/W303 strains for the genetic studies (30). The
ded1::HIS3 strain was as previously described (31). It was
transformedwith plasmids expressingHA-Ded1 (29). Dele-
tions and mutations of Ded1 and subcloning of the dif-
ferent genes were done by oligonucleotide-directed PCR.
The cbp20::KANMX4 strain (Euroscarf) was derived from
BY4742. The CBP20 gene in the pRSETC20 plasmid (32)
was PCR amplified with oligonucleotides containing the
SpeI and XhoI sites, cloned into the equivalent sites in
the p415-PL and p424-PL plasmids (29) and transformed
into the deletion strain. The expressed protein contained
an amino-terminal HA tag. SpeI and XhoI sites were intro-
duced into the CBP80 pMalE clone (33) and then CBP80
was cloned into the equivalent sites of the p415-PL plas-
mid. The PL10 gene in the pRS315 plasmid with a GDH
promoter and PGK terminator was as previously described
(18). The DDX3X pTrcHis clone (34) was subcloned into
SpeI-XhoI sites of p424-PL. TheBELLEYEp181 construct
was as previously described (35).
The GFP versions of DED1 and Δ30N-ded1, containing
SalI-XhoI sites, were subcloned into the SalI-cut pYM27
plasmid (Euroscarf Toolbox) containing the EGFP (en-
hanced green fluorescent protein) gene. This yielded pro-
teins with carboxyl-terminal EGFP tags. SpeI-XhoI sites
were introduced and the fusion construct was subcloned
into the equivalent sites of p416-PL and p414-PL plasmids
lacking the HA tags. The Δ30N-ded1 also was cloned into
the SphI-NheI sites of p416 containing the mCherry gene
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from pSL1 (36). The EGFP tag was integrated at the 3′ ter-
minus of the DED1 gene in the chromosome along with
a KANMX4 marker using pYM27 as previously described
(37). The carboxyl-terminal GFP tag of Cbp80 was con-
structed by inserting SalI and XhoI sites into the pYM27
plasmid containing CBP80 and then cloning the fragment
into the XhoI-cut p414-PL and p416-PL plasmids. All con-
structs were verified by sequencing.
In situ localization
Most of the in situ studies were done with the mex67-
5/xpo1-1 strain KWY610, where the expressed mex67
and xpo1 genes contained temperature-sensitive muta-
tions [mex67::HIS3(pUN100(CEN LEU2)mex67-5)
xpo1::TRP1 xpo1-1::HIS3; (38)]. Cells were incubated
for 30–60 min at 36◦C to block nuclear export. The
mex67-5 strain was treated similarly (39). The crm1T539C
(xpo1-T539C) strain (40) was incubated for 1 h with 200
nM leptomycin. The wildtype G50 strain was an ADE2
derivative of W303-1A (ura3-1 trp1-1 leu2-2,112 his3-11,15
can1-100 RAD5 ADE2; a gift from Michael Lisby). Cells
were typically grown to an OD595 of ∼0.4 at 24–25◦C.
Cells were fixed with 3.7% formaldehyde for 10 min with
mixing, incubated for 10 min with 0.1 g/ml DAPI (4′,6-
diamidino-2-phenylindole), washed three times with deion-
ized H2O and resuspended in H2O. Living cells were DAPI
stained with 1 g/ml, final, DAPI added to medium and
incubated for 2–3 h with mixing. Cells were washed three
times and resuspended in deionized H2O. Cells were vi-
sualized with a Carl Zeiss Axio Observer.Z1 microscope
connected to an ORCA-R2 charge-coupled-device camera
(Hamamatsu) using the Carl Zeiss AxioVision version 4.8.2
software. Images were edited using Adobe Photoshop CS3.
Recombinant protein expression and purification
Ded1-His6 and eIF4A-His6 were expressed in pET22b (No-
vagen) and purified as previously described (5,29). Restric-
tion sites were introduced by PCR into the pRSETC20
plasmid containing CBP20 and the product was subcloned
into the NdeI-BamHI sites of pET19b (Novagen). The
His6-Cbp20 protein was purified as for the others. GST-
NAB2-HIS6 clone was described previously (41); the ex-
pressed protein was purified as for Ded1-His6 on nickel-
agarose columns. CDC33 (eIF4E) was cloned into the
NdeI-BamHI sites of pET15b (Novagen) and PAB1 in the
XhoI-BamHI sites of pET19b; the expressed proteins con-
tained amino-terminal His6 tags and they were purified as
described for Ded1-His6. GLE1 in the BG1805 plasmid
(Open Biosystem) was subcloned into the BamHI site of
pET19b. The sec63 domain of BRR2 was cloned and ex-
pressed as previously described (42). TheMalE-Cbp80 pro-
tein was expressed and purified as described elsewhere (33).
The amino-terminal GST-tagged eIF4G1 fragments (1-596,
542-952, 882-952) were constructed by cloning the PCR-
generated gene fragments into the BamHI-SmaI sites of
pGEX-2T (GEHealthcare) and the expressed proteins were
purified on glutathione Sepharose columns eluted with 10
mM reduced glutathione, 20 mM Tris–HCl, pH 7.5, 100
mMNaCl and 2mMdithiothreitol (DTT). The gene coding
for eIF4G9 in pGEX-1Twas expressed and the protein pu-
rified as previously described (43). All constructs were ver-
ified by sequencing.
Immunoglobulin G-protein A Sepharose bead pull-down ex-
periments
Cell extracts were made by harvesting cells at an OD595
around 0.6–0.8 by centrifugation, and resuspending the
cells in a 40% volume (v/g) of a TpA buffer contain-
ing 10 mM 4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic
acid (HEPES), pH 7.9, 100mMKCl, 0.5 mMDTT, 1.5mM
MgCl2 and 1X protease inhibitor cocktail (Roche Complete
EDTA-free). Cells were then quick frozen by dripping the
suspension in liquid nitrogen and the resulting cell beads
were stored at −80◦C until needed. The cells were ruptured
while frozen with a RetschMM400 ball mill five times at 10
Hz for 3 min with a 25-mm steel ball. The grinding jar was
cooled in liquid nitrogen between grindings. The cell pow-
der was stored at−80◦Cuntil needed. The cells were thawed
on ice and slowly made 200 mM in KCl over 30 min, with a
2 M stock solution, to lyse the nuclei. The extract was clar-
ified by centrifugation for 30 min at 15 000 rpm in a Beck-
man JA20 rotor at 4◦C. The supernatant was further clari-
fied by centrifugation for 1 h at 37 000 rpm in a Beckman
60Ti rotor at 4◦C. The supernatant was recovered,made 100
mM inKCl,made 10% in glycerol and frozen at−80◦Cuntil
needed.
Ded1-immunoglobulin G (IgG) was crosslinked to pro-
tein A-Sepharose CL-4B beads (GE Healthcare) with glu-
taraldehyde as described elsewhere (44). We typically used
1–2 ml of cell extracts incubated with 30–75 l of Ded1-
IgG Sepharose beads. Generally, 1 g/ml of RNAse A was
added during the incubation. Material was generally incu-
bated 1–2 h with mixing at 4◦C. Beads were washed three
times with 1 ml phosphate buffered saline (Euromedex), the
bound proteins were eluted with 400 l of 200 mM glycine,
pH 2.5, for 15–30 min with mixing at room temperature.
The solution was titrated to a neutral pH with concentrated
NaOH, made 150 g/ml in sodium deoxycholate and the
proteins were precipitated using 15%, final, trichloroacetic
acid (TCA). The pellet was washed with cold acetone, dried
and resuspended in loading buffer containing 67 mM Tris–
HCl, pH 6.8, 1.3% sodium dodecyl sulphate (SDS), 2% -
mercaptoethanol, 0.07% bromophenol blue and 10% glyc-
erol. The eluted proteins were separated on SDS-Laemmli
gels, transferred to Hybond-C super membranes (Amer-
sham Biosciences) and probed with IgG against Ded1 (31),
eIF4A (a gift from P. Linder), eIF4E (45), HA tag (Cov-
ance), Cbp80 (46), Dhh1 (47) Nab2 (Santa Cruz Biotech-
nology), eIF4G1 and eIF4G2 (48), Pab1 (49) andGle1 (50).
Horseradish peroxidase-conjugated antimouse (Promega),
antirabbit (Promega) and antigoat (Santa Cruz Biotechnol-
ogy) were used as secondary antibodies, and the signals
were revealed with a Clarity Western ECL Substrate kit
(Bio-Rad).
Proteins were identified by nano-liquid-chromotagraphy-
electronspray mass spectrometry (nanoLC-MS/MS) using
the Plateforme Prote´omique de Strasbourg service at the
University of Strasbourg. For the pull-down experiments
of yeast extracts, the proteins were electrophoretically sep-
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arated on a 10% SDS-Laemmli polyacrylamide gel, the gel
was stained with colloidal Brilliant Blue G (Sigma) and the
entire gel was sent to the service. The service cut each lane
of the gel into 48 pieces and then incubated the pieces with
trypsin. The eluants were combined into six fractions that
were injected into the nanoLC-MS/MS.
Other pull-down experiments
We used 7 l of 7-methyl-GTP Sepharose beads (GE
Healthcare) equilibrated in 100 l of TpB buffer contain-
ing 20 mM HEPES, pH 7.9, 100 mM KCl, 2 mM MgCl2
and 2 mM DTT. The beads were then incubated with 5
g of purified eIF4E or Cbp20 for 90 min on ice and then
washed three times with 1 ml of TpB buffer. We added 5
g of the purified proteins of interest with 50 U of RNase
I, incubated 90 min on ice, washed three times with 1 ml
TpB buffer and eluted the bound proteins with 15 l of 1
mM 7-methyl-GTP (Sigma) over 90 min at 4◦C. The same
protocol was used for the pull-down experiments with glu-
tathione Sepharose 4B (GE Healthcare) and amylose resin
(BioLabs) except the bound proteins were eluted with 15 l
of 10 mM reduced glutathione and 15l of 10 mMmaltose,
respectively.
In vitro ATPase assays
The ATPase reactions were as previously described except
that the currently available whole yeast RNA from Sigma
(type III) contained inhibitors (4). Consequently, we use
whole yeast RNA from Roche, which was phenol extracted
and fractionated on a DEAE-Sephadex column using a
NaCl gradient to remove inhibitors that were present. The
fractions that stimulated the ATPase activity the most were
combined and used for the subsequent assays. We typi-
cally used 0.45 g/l in the reaction. Assays were done
with a defined RNA substrate using a T7-RNA-polymerase
runoff transcript of an EcoRI-cut plasmid containing the
3′ untranslated region (UTR) of the CYC1 gene as previ-
ously described (51). Transcription was done with the T7-
MEGAshortscript kit (Ambion). This 202 nucleotide-long
RNA was capped and polyadenylated with the T7 mScript
Standard mRNA kit (Cellscript). Proteins were preincu-
bated in the reaction mix containing the RNA for 20 min
on ice. Samples were then placed at 30◦C, and the reactions
were initiated by making them 1 mM in ATP.
Polysome profiles
Yeast cultures were grown to an OD595 of ∼0.8 at 30◦C and
then cycloheximide (Sigma) was added to a final concentra-
tion of 100g/ml. The cultures were incubated with mixing
on ice for 10–15 min, and the cells were harvested by cen-
trifugation. In the rapamycin experiments, the cultures were
made 0.5 g/ml in rapamycin (InvivoGen) at an OD595 of
∼0.5 and then incubated ∼2 h at 30◦C prior to adding the
cycloheximide. Cells from 500-ml cultures were collected by
centrifugation, washed and the pellets resuspended in 500
l of a lysis buffer containing 20 mM Tris–HCl, pH 7.5, 50
mMNaCl, 5mMMgCl2, 1mMDTTand 0.1mMethylene-
diaminetetraacetic acid. Cells were frozen at −20◦C until
needed.
Cells were extracted with a FastPrep-24 homogenizer
(MP Biomedical) in the presence of 1X protease inhibitor
cocktail using a dry ice cooled rotor and acid-washed glass
beads (Sigma; 425–600 m). Samples were lysed at 6.5M/S
four times for 30 s, with the rotor cooled between extrac-
tions. Extracts were passed through MiniBioSpin columns
(BioRad) and then clarified by centrifugation two times for
10 min at 12 000 g in an Eppendorf 5415R centrifuge. The
resulting supernatants were loaded onto 12 ml gradients,
consisting of 7–47% sucrose in lysis buffer, at an OD260 of
10–12 (100–200 l of extract) and then centrifuged in an
SW41ti rotor (Beckman) at 39 000 rpm for 3 h at 4◦C. Half
milliliter fractions were collected from the top of the gra-
dients with a Retriever 500 (ISCO) fraction collector and a
Type 11 Optical unit (ISCO) with 254-nm filters. Generally,
the proteins were precipitated by making the solutions 150
g/ml, final, in sodium deoxycholate, then adding TCA to
15% final. The solutions were centrifuged, and the pellets
washed with cold acetone, dried and resuspended in load-
ing buffer. The recovered proteins were electrophoretically
separated by SDS-Laemmli gels, transferred to membranes
and then identified with various IgGs (see above). Samples
analyzed by nanoLC-MS/MS were first further purified by
Ded1-IgGpull downs, washed and precipitated as described
above. The resulting dried pellets were then sent to the Plate-
forme Prote´omique de Strasbourg service for analysis.
RESULTS
Functional homologs of Ded1
Because Ded1 is a homolog of a subset of DEAD-box
proteins involved in cell cycle and developmental regula-
tion in other organisms, we were interested in determining
the degree of functional complementation of this subfam-
ily of proteins in yeast, which might help clarify the role(s)
of Ded1 in vivo. Drosophila Belle (35), mouse PL10 (18),
Schizosaccharomyces pombeDed1 (52) and humanDDX3X
(53) were shown to complement yeast cells deleted forDed1.
Likewise, we previously showed that the more distantly re-
lated Vasa protein from Drosophila could weakly com-
plement yeast (5). However, the degree of complementa-
tion was not evident for DDX3 and PL10. In these experi-
ments, we directly compared the complementation of PL10,
DDX3X and Belle with Ded1.
When selected on plates containing 5-FOA, all three pro-
teins could complement the deletion of Ded1, but with sig-
nificant differences (Supplemental Figure S1). PL10 showed
the best growth, DDX3X supported weaker growth, while
Belle poorly complemented the Ded1 deletion. Cells trans-
formedwith theVasa gene showed no apparent growth after
3 days, but slight growth was apparent after longer incuba-
tion times (5). The Belle construct was expressed with the
Ded1 promoter and terminator, while the other constructs
were expressed with strong constitutive promoters. We pre-
viously showed that Ded1 and other yeast DEAD-box pro-
teins inhibit growth when highly expressed (4). This is con-
sistent with the reduced complementation ofDed1when ex-
pressed off the high-copy plasmid with the strong alcohol
dehydrogenase (ADH) promoter relative to the equivalent
construct in the low-copy plasmid (Supplemental Figure
S1). However, no difference was seen when Belle or DDX3
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was expressed off low- and high-copy plasmids. Hence,
complementation by the Ded1 homologs was probably not
significantly affected by the level of protein expression.Nev-
ertheless, we cannot rule out a combination of both stimu-
latory and inhibitory effects of the homologs in these as-
says. Overexpression of the unrelated DEAD-box proteins
eIF4A, which also is implicated in translation initiation,
and Dhh1 failed to support growth (Supplemental Figure
S1). Thus, only the tested Ded1 homologs could partially
replace Ded1 in the cell, which pointed to a functional con-
servation of the proteins among eukaryotes.
Ded1 shuttled between the cytoplasm and the nucleus
The Ded1 subfamily of proteins contains a leucine-rich nu-
clear export signal (NES) on the amino terminus (54). Both
Xenopus An3 and human DDX3X are known to shuttle
between the cytoplasm and nucleus (54–58), but Ded1 was
previously shown to be predominately located in the cyto-
plasm (18). Nevertheless, it was possible that Ded1 shuttled
between the nucleus and cytoplasm at low levels that were
not readily detectable by the indirect immunofluorescence
that was used in those experiments. To test this, we con-
structed a fusion protein between Ded1 and the GFP that
was expressed from the low-copy p416-PL plasmid. This
construct supported nearly wildtype growth at 18 and 30◦C
in cells deleted for wildtype DED1, but it showed slightly
reduced growth at 36◦C (Supplemental Figure S2). Simi-
lar results were obtained with the plasmid-expressed HA-
tagged Ded1, which suggested that the GFP tag, per se, did
not significantly alter the properties of Ded1. To verify this,
we integrated the GFP gene at the 3′ terminus of DED1 in
the chromosome. In this case, cells grew like the wildtype
strain at all the temperatures tested (Supplemental Figure
S2). Thus, the higher, or constitutive, expression levels of
the plasmid-encoded proteins probably caused the slightly
reduced growth at 36◦C.
We next asked where the Ded1-GFP fusion protein was
located within the cell. Fluorescence microscopy of living
cells revealed that the protein was primarily located within
the cytoplasm, but the nuclei showed a faint signal rela-
tive to the vacuoles/lysosomes. To verify this, we fixed the
cells and then stained themwith DAPI to identify the nuclei
(Figure 1A and B). These experiments confirmed that Ded1
was largely excluded from the nuclei, but that the faint sig-
nals corresponded to the nuclei rather than to the vacuoles.
Both plasmid-expressed and integrated Ded1-GFP showed
the same distributions, which indicated that the expression
levels did not alter the results. However, the intensity of the
Ded1-GFP signal varied between cells in both the plasmid-
borne and integrated cells. This implied that the expression
levels of Ded1 were variable between cells (Figure 1A and B
and Supplemental Figure S3). Thus, our results were con-
sistent with the possibility that a small amount of Ded1 was
located in the nucleus.
Proteins shuttle between the nucleus and cytoplasm
through the nuclear export receptor Crm1, also known as
Xpo1 in yeast, which recognizes the NES of the proteins
and that is part of the nuclear pore complex (59). We rea-
soned that Ded1 may be maintained at low concentrations
in the nucleus, and that this regulation may be mediated
through Xpo1. Crm1 is selectively inhibited by the antibi-
otic leptomycin B from Streptomyces (60), but Xpo1 from
S. cerevisiae is resistant to this drug. Therefore, we used a
mutant strain where the XPO1 gene was deleted and the
plasmid expressed copy contained a threonine to cysteine
mutation at position 539 that conferred sensitivity to the
drug (40). We transformed this strain with the DED1-GFP
plasmid and analyzed the distribution of the protein after
treatment of the cells with 200 nM of leptomycin B by flu-
orescence microscopy (Supplemental Figure S3). The cells
showed a high degree of variability, but a few percent of the
cells showed a very strong accumulation of Ded1-GFP in
the nuclei. This indicated that Ded1 did shuttle between the
nucleus and cytoplasm, but that Ded1 did not use exclu-
sively the Xpo1/Crm1 pathway.
The mRNAs are typically exported from the nucleus
through another transport system involving Mex67 [TAP
(Tip-associated protein) in metazoans; reviewed by (61)].
It was possible that Ded1 associated with mRNAs also
was being transported through this pathway. Therefore,
we used a different yeast strain that had both XPO1 and
MEX67 deleted from the chromosome and that expressed
temperature-sensitive variants of the proteins from plas-
mids [mex67-5/xpo1-1; (38)]. When we transformed this
strain with theDED1-GFP plasmid, we saw very intense flu-
orescence in the nuclei at the nonpermissive temperatures
in the majority of cells (>50%, Figure 1C), but not at the
permissive temperatures (Figure 1D). Moreover, the accu-
mulation of Ded1 in the nuclei was reversible; cells incu-
bated at 36◦C and then left at room temperature for 30 min
showed little Ded1-GFP in the nuclei. This meant that the
transport of Ded1 was highly dynamic. Both the Xpo1 and
Mex67 pathways were used because a strain expressing only
the mex67-5 mutant showed only a few percent of the cells
with Ded1-GFP strongly accumulated in the nuclei (Sup-
plemental Figure S3). Thus, there were clearly cell-to-cell
differences that suggested that the primary export pathway
varied between cells.
Transport was not strongly dependent on the enzymatic
activity of Ded1 because a Ded1-GFP variant containing
the P-loopmutationK192A showed only a small increase in
some of the nuclei of the mex67-5/xpo1-1 strain under per-
missive conditions (data not shown). This mutation elim-
inates the ATPase activity and reduces the RNA-binding
affinity of Ded1 in vitro (4). This result was in contrast to
that previously obtained for An3, where Crm1-dependent
export was significantly reduced with a protein mutated in
motif II (62). However, we cannot rule out the possibilities
that some cells weremore dependent on the enzymatic activ-
ity of Ded1 for nuclear export than others or that only one
pathway was dependent on this activity. In contrast, no dif-
ferenceswere seen between thewildtype and theK192Amu-
tant Ded1-GFP at the nonpermissive temperatures, which
indicated that the nuclear import of the Ded1-GFP was not
strongly affected (data not shown).
As a control, we looked at the cellular location of the
GFP-tagged, cap binding protein Cbp80, which is known
to be predominately a nuclear protein (63). Consistent with
this, Cbp80-GFP was almost exclusively found in the nuclei
(Figure 1E). This was in contrast to Ded1-GFP where a de-
tectable signal was always present in both the nucleus and
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Figure 1. Ded1 shuttled between the cytoplasm and nucleus. (A) and (B) Fluorescence microscopy of cells that were fixed with formaldehyde when stained
with DAPI to reveal the nuclei and mitochondria (seen as speckles). Ded1-GFP was primarily located in the cytoplasm of wildtype (G50) cells at all
the temperatures tested. (C) In contrast, Ded1-GFP shows a strong nuclear location in the mex67-5/xpo1-1 mutant when incubated at nonpermissive
temperatures for 30 min in living cells stained with DAPI. (D) Fluorescence microscopy (GFP) and Nomarski interference contrast microscopy of living
yeast cells. Ded1-GFP was mostly located in the cytoplasm of mex67-5/xpo1-1 cells at the permissive temperatures (24◦C), but a small amount was visible
in the nuclei as well (arrows). The vacuoles/lysosomes are indicated with arrowheads. (E) In contrast, Cbp80-GFP was almost exclusively located in the
nuclei. (F) Ded1-GFP that was deleted for the 30 amino-terminal residues containing the NES sequence (30N) and the eIF4E binding site accumulated
in the nuclei of yeast even in wildtype cells.
cytoplasm under all conditions (Figure 1A–D). Finally, we
obtained very strong nuclear localization, even in the wild-
type cells, when we deleted the 30 amino-terminal residues
containing both the eIF4E-binding motif and the NES se-
quence from Ded1 (Figure 1F). However, there was signif-
icant cell-to-cell variability that ranged from little accumu-
lation to very high. The nuclear-accumulated Ded1 colo-
calized with Cbp80 (Supplemental Figure S4). These data
demonstrated that Ded1 shuttles between the nucleus and
cytoplasm, and that it is exported by both the Mex67- and
Xpo1-dependent nuclear-export complexes in cells grow-
ing at early exponential phase. Similar results were ob-
tained with DDX3X (55,56,58). Thus, it was likely that
Ded1 formed complexes with both nuclear and cytoplasmic
factors, and that the Ded1 exported through the Mex67-
dependent pathway was probably associated with mRNAs
as part of an messenger ribonucleoprotein (mRNP) com-
plex. Likewise, a subset of mRNPs are transported through
the Xpo1/Crm1 pathway [reviewed by (64)], although this
is a relatively minor pathway in yeast (40). DDX3X was
found to be exported by this pathway in mRNPs bound
with eIF4E instead of the cap binding complex (CBC) pro-
teins (58). In contrast, because Ded1 contains a NES, it
may be maintained at low levels in the nucleus through a
karyopherin-mediated export by the Xpo1-dependent path-
way. Finally, it also was possible that Ded1 was associated
with the export of rRNAs, which involves both the Mex67
and Xpo1 proteins (64).
Ded1 genetically interacted with cytoplasmic and nuclear
mRNP factors
DDX3X interacts with some components of the cytoplas-
mic, cap binding, eIF4F complex, which is involved in
translation initiation of mRNAs (26,65). The eIF4F com-
plex consists of the 7-methylguanosine binding protein
eIF4E, the scaffolding protein eIF4G, and the DEAD-box
helicase eIF4A [reviewed by (9)]. The eIF4G protein exists
as two isoforms in yeast consisting of a highly-expressed
eIF4G1 and a lesser-expressed eIF4G2. The polyadenosine
binding protein Pab1 binds eIF4G and thereby loops back
themRNA to form a circle. It was shown recently that Ded1
physically interacts with the carboxyl-terminal domain of
eIF4G1 (66). The nucleus contains an analogous structure
called the nuclear cap binding complex [CBC; reviewed
by (9,67)]. This complex consists of the 7-methylguanosine
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binding protein Cbp20 and an accessory protein, Cbp80.
DDX3X in the nucleus was found associated with the nu-
clear CBC proteins (26,56,58,68,69). In addition, the nu-
cleus contains the polyadenosine binding protein Nab2 that
is involved in regulating polyadenylation of mRNAs and in
mRNA export [reviewed by (70)].
We reasoned that, since Ded1 was present in the nucleus,
it might interact with the nuclear cap-binding complex. To
test for this, we used a slow-growth variant of Ded1 that
was mutated in the Q motif involved in adenine binding
of ATP [Ded1-F162C; (71)]. We then overexpressed various
candidate proteins to see if they could partially restore the
growth phenotype (Figure 2A). The overexpressed Cbp20
and eIF4G2 proteins restored the growth to nearly wild-
type levels. Cbp80 partially restored growth, while Pab1 and
eIF4G1 promoted growth at 18◦C but inhibited growth at
the higher temperatures. This latter result pointed to a syn-
thetic lethal (inhibitory) effect of the overexpressed proteins.
Indeed, we saw growth inhibition at all temperatures when
we overexpressed Pab1 and eIF4G1 in a strain expressing
the wildtype Ded1, which indicated that the inhibitory ef-
fects were unrelated to Ded1 (Figure 2B). Thus, all five of
the tested proteins interacted genetically with Ded1.
Oddly, themulticopy suppression ofDed1mutants by the
other proteins was dependent on the location of the muta-
tion. Thus, in contrast to the preceding results, we found
that a slow-growth mutant in motif IV (F405C) was better
suppressedwithCbp80 thanwithCbp20 (Figure 2C).Motif
IVmutants dissociate the cooperative binding betweenATP
and the RNA substrates (72). However, there was no strong
correlation between the multicopy suppression and the spe-
cific motif mutated; a different Q motif mutant, T166Q,
was better suppressed by Cbp80 than by Cbp20 (data not
shown).
The multicopy suppression worked in reverse for some
of the proteins; i.e. overexpressed Ded1 was able to sup-
press the slow-growth phenotype of a strain deleted for
Cbp20 (Figure 2D). The strain deleted for Cbp80 showed
a slight effect with overexpressed Ded1, but this deletion
strain had a more severe phenotype than for Cbp20 (data
not shown). Finally, we obtained a slight slow-growth phe-
notype whenwemutated the putative eIF4E-binding site on
Ded1 (Y21A/L26A; Figure 2E). This was consistent with a
previously demonstrated genetic link to eIF4E (19). These
genetic results were compatible with Ded1 interacting with
both cytoplasmic and nuclear cap-binding complexes.
Ded1 was associated with large RNP complexes
We next asked what were the factors that were physi-
cally associated with Ded1 in the cell. We initially tried
the double-affinity purification procedure that uses Ded1
fused to the protein A and the calmodulin-binding pro-
teins to isolate complexes containing Ded1 from cell ex-
tracts [TAP-tag method; (73)]. However, the long loading
times on the columns and poor recovery of Ded1 pre-
cluded reliable identification of the cofactors. Neverthe-
less, the results from theMALDI-TOFMS (matrix-assisted
laser desorption/ionization time of flight mass spectrom-
etry) analyses were consistent with Ded1 interacting with
the translationalmachinery (data not shown). Therefore, we
used IgG against Ded1, attached to protein A-Sepharose
beads, to pull down the complexes in yeast extracts. We
tried various conditions and found that light digestion of
the extracts with RNase A gave the best yields and qual-
ity of material. Western blot analyses of the separated pro-
teins revealed the expected proteins eIF4E, eIF4G1, Pab1,
Cbp20, Cbp80 and Nab2 (Figure 3). We also recovered a
weak signal for eIF4G2 in some experiments. Ded1was pre-
viously found to interact with Dhh1 and Gle1 (74,75), and
we were able to identify these proteins as well (Figure 3).
Moreover, we recovered eIF4A. Thus, Ded1 was associated
with both nuclear and cytoplasmic proteins that are known
components ofmRNARNPs. These results were verified by
nanoLC-MS/MS analysis of the polyacrylamide gels (Sup-
plemental Tables S1 and S2).
There was significant variability in the degree of enrich-
ment between the different proteins relative to the crude
extract and the pre-immune IgG. Pab1 was only slightly
enriched, while eIF4E was strongly enriched. The expres-
sion levels of the different proteins vary enormously, from
nearly 200 000 copies per cell for Pab1 to about 1000 copies
per cell for Gle1 (http://yeastgenome.org). Ded1 was calcu-
lated to be present at about 30 000 copies per cell (76). This
partially accounted for the difference in enrichment on the
IgG beads relative to the extract. However, the cytoplas-
mic eIF4F-associated proteins were clearly more enriched
relative to the extract than the nuclear CBC complex pro-
teins. This was consistent with Ded1 having primarily a cy-
toplasmic location, as was seen with the Ded1-GFP within
the cell. The exception was Nab2 that was highly enriched,
even though it is typically located primarily in the nucleus
[Figure 3; (70)]. Nab2 is present at about 10 000 copies per
cell (http://yeastgenome.org). Thus, the stoichiometry of the
different proteins was complex, which indicated that mul-
tiple different RNPs were present. Moreover, the binding
affinities of the different factors were likely different, which
might result in the preferential loss or retention of certain
factors relative to the others from the isolated complexes.
Nevertheless, the data were consistent with Ded1 binding
to both nuclear and cytoplasmic RNP complexes.
Ded1 was a 7-methylguanosine cap-associated factor
The preceding experiments indicated that Ded1 was in com-
plexes containing the identified proteins, but they did not
demonstrate a direct or functional interaction between the
proteins. However, it seemed likely that Ded1 was part of
the nuclear and cytoplasmic cap-binding complexes. To test
this, we purified the different recombinant proteins from
E. coli (Supplemental Figure S5) and tested their ability to
form complexes on 7-methyl-GTP Sepharose beads. Both
Cbp20 and eIF4E have high affinity for 7-methylguanosine.
We bound these proteins to the beads, added various com-
binations of the purified proteins and then eluted the pro-
teins retained (Figure 4). To facilitate the analyses, we
used a shorten version of eIF4G1 (eIF4G9; amino acids
160–492) that was known to retain its capacity to interact
with Pab1 and eIF4E (43). Of the proteins tested, only the
polyadenosine-binding protein Nab2 showed a weak, non-
specific affinity for the beads.
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Figure 2. Cap-associated factors were genetically linked to Ded1. Cells transformed with plasmids expressing the indicated proteins were serially diluted
by factors of 10, spotted on synthetic minimal-medium plates lacking tryptophan (p424 plasmids) or uracil (p426 plasmids) and incubated at the indicated
temperatures. Plates were incubated for 3 days at 30 and 36◦C, and for 8 days at 18◦C. (A) Cells expressing the slow-growth mutant Ded1-F162C of
the Q motif were transformed with plasmids overexpressing the indicated proteins. The p424 was an empty plasmid control. (B) Pab1 and eIF4G1 were
inhibitory when overexpressed in cells expressing wildtype Ded1. (C) Multicopy suppression of cells expressing the slow-growth mutant Ded1-F405C of
motif IV. Cells were transformed with plasmids overexpressing Cbp20 and Cbp80. (D) Ded1 was a multicopy suppressor of cells deleted for cbp20. (E)
Cells expressing Ded1 mutated in the eIF4E-binding motif (Ded1-4E; Y21A/L26A) gave a slow-growth phenotype relative to the wild type (Ded1) when
expressed off the low copy p415-PL plasmid.
As expected, eIF4G9 and Pab1 formed a complex with
eIF4E, although the interactions with Pab1 appeared to be
weaker (Figure 4A). Pab1 interacts indirectly with eIF4E
through the scaffolding protein eIF4G, and it is normally
bound to the polyadenosine tail of mRNAs, which signif-
icantly enhances its affinity for eIF4G (77). Ded1 was re-
tained by eIF4E under all the protein combinations tested,
which indicated that Ded1 directly contacted eIF4E. How-
ever, we reproducibly recovered less protein when Pab1 was
present with Ded1 in the mixture. This suggested that Ded1
and Pab1 had overlapping binding sites with the other fac-
tor(s), which were most likely mediated by eIF4G1. Thus,
we cannot rule out the possibility that the lower recovery of
all four proteins reflected a heterogeneous mix of complexes
constituting different combinations of the proteins.
We obtained similar results for proteins binding to Cbp20
(Figure 4B). As expected, Cbp80 showed a high affinity
for Cbp20, but surprisingly we also obtained an interac-
tion with Nab2. The interactions between Nab2 and Cbp20
are less well characterized than those between Pab1 and
eIF4G, but they were thought to be mediated by the RNA
because RNase-treated extracts showed reduced interac-
tions between the proteins (78,79). Our results indicated
that Nab2 was capable of forming direct protein–protein in-
teractions as well. Thus, Nab2 may fold-back the mRNA in
the nucleus in a way analogous to what Pab1 does in the cy-
toplasm. Regardless, Ded1 was weakly associated with all
the combinations of proteins, which indicated that Ded1
formed direct protein-to-protein interactions with Cbp20.
Both the eIF4E and the CBC complexes were resistant to
both RNase A and RNase I, which showed that the inter-
actions were not mediated by contaminating RNAs bound
to the purified proteins. These results were consistent with
the previous observation that Ded1 binds eIF4E-eIF4G1 in
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Figure 3. Ded1-IgG pull-down experiments. Yeast extracts were incubated
with Ded1-IgG-Sepharose beads, washed, the proteins eluted and then the
recovered proteins were separated by an 8% SDS polyacrylamide gel elec-
trophoresis (PAGE) for Cbp80 and eIF4G1, and by an 10% SDS PAGE
for the others. IgG, rabbit serum after induction with injected, purified,
Ded1 protein; Pre, rabbit pre-immune serum; Ext, the equivalent of 1 l
of yeast extract. Note that for each set of experiments, the material was
analyzed on the same gel with the same extract; an empty lane was placed
between the pull-down lanes and the extract lanes to avoid potential cross-
contamination. The separated proteins were transferred to membranes,
cut into strips and probed with antibodies against the indicated proteins.
Cbp20was expressed from a plasmid incorporating an amino-terminalHA
tag, and it was detected with IgG against HA. The other proteins were de-
tected from the wildtype BY4742 strain with antibodies specific to each
protein. The molecule weight markers were PAGE Ruler from Thermos
Scientific.
an RNA-independent fashion on 7-methyl-GTP Sepharose
beads (66).
Ded1 physically interacted with mRNP cap factors
The preceding experiments demonstrated direct physical in-
teractions between Ded1 and cap-binding proteins. How-
ever, it was possible that some factors were indirectly asso-
ciated with Ded1 through their interactions with the other
proteins. Therefore, we individually tested various purified
proteins for their ability to be retained by Ded1 fixed to
Ded1-IgG Sepharose beads (Figure 5A). As a control, we
incubated a mixture of the proteins with the beads in the
absence of Ded1. Only Gle1 and Nab2 showed a weak non-
specific binding. The beads retained all of the indicated cap-
associated factors in the presence of Ded1 except eIF4A.
Both Pab1 and Cbp80 showed faint signals, but their pres-
ence was verified by western blot analysis. Ded1 bound to
the beads also retained Gle1. This was consistent with pre-
vious observations that Gle1 physically and genetically in-
teracts with Ded1 (75). As a control, we used the sec63 do-
main of Brr2 that is associated with protein–protein inter-
actions (80); no interactions were detected, which indicated
that only specific proteins were retained by Ded1. To ver-
ify the interactions between Ded1 and Cbp80, we bound
a fusion construct between Mal-E and Cbp80 on amylose
beads and tested for the ability to retain Ded1. Both Ded1
and Cbp20 were detected by western blot analysis in frac-
tions containing MalE-Cbp80, but not in those lacking the
Figure 4. Ded1 was retained by cytoplasmic and nuclear cap-binding
complexes. The indicated proteins were incubated with 7-methyl-GTP
Sepharose beads, washed and then eluted with 1 mM free 7-methyl-GTP.
The eluted proteins were separated by electrophoresis on 10% SDS poly-
acrylamide gels (SDS PAGE) and stained with Coomassie blue. (A) Pro-
teins associated with the predominately cytoplasmic eIF4E protein bound
to the beads. The eIF4G9 protein consisted of amino acids 160–492 of
eIF4G1. Pab1 (Pab) gave a weak signal, but its presence was verified by
western blot analysis. (B) Proteins associated with the predominately nu-
clear Cbp20 protein bound to the beads. Nab2 had a very weak affinity for
the beads in the absence of the other proteins. The markers reflect the sizes
of the Prestain Protein Ladder (Euromedex).
fusion protein (Figure 5B). TheMal-E protein bound alone
to the beadswas unable to retain the proteins, which demon-
strated that the interactions were mediated through Cbp80
(data not shown).
Previous workers have demonstrated a direct interac-
tion between Ded1 and the carboxyl-terminal domain of
eIF4G1 containing the RNA-binding motif RNA3 [Figure
5D; (66)].We were interested in knowing what other regions
of eIF4G1 might interact with Ded1. Thus, we constructed
or obtained various constructs that expressed different frag-
ments of eIF4G1 containing the previously identifiedmotifs
[Figure 5D; see (48) and references therein]. All the frag-
ments bound to glutathione beads that contained the RNA-
binding motifs were able to retain Ded1 with varying ef-
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Figure 5. Ded1 physically interacted with the cap-associated factors. (A) Ded1 was bound to protein A Sepharose beads crosslinked to IgG against Ded1,
incubated with the indicated purified proteins, washed and the eluted proteins separated by 10% SDS PAGE. The gel was subsequently stained with
Coomassie blue. Note that Cbp80 was weakly stained, but it was clearly visible on the original gel. The ‘nonspec’ lane was a mix of all the purified proteins
incubated with the resin in the absence of Ded1. (B) MalE-Cbp80 was bound to amylose resin beads (Biolabs), incubated with the indicated purified
proteins, washed and the eluted proteins separated by 10% SDS PAGE. The gel was analyzed by western blot with IgG against Ded1, Cbp80 and the
His6 tag of Cbp20 (Roche). Two identical gels were used to probe for Ded1 and Cbp20 because different secondary antibodies were used. Aliquots of the
purified proteins (0.1 g) are shown as markers. Note the Cbp20 protein migrated slower in the binding assay lanes due to the higher salt concentrations.
(C) Purified GST-eIF4G1 fusion fragments bound to glutathione agarose beads, were incubated with Ded1, washed, eluted with reduced glutathione and
separated by 10% SDS PAGE, which was subsequently stained with Coomassie blue. *The exception was the eIF4G-His6 fragment 387–952 that was
retained by Ded1 bound to IgG-protein A Sepharose beads as in panel (A). Note that the 882–952 fragment gave a weak signal that was clearly visible
on the original gel. For unknown reasons, the 1–387-GST fragment migrated as an aberrantly large protein. (D) The different fragments of eIF4G1 that
were used in these experiments that show the locations of the previously identified binding motifs. RNA1–3 motifs bind the mRNA; motifs Pab1, eIF4E
and eIF4A form direct protein–protein interactions with the corresponding proteins; and the solid line in the eIF4A-binding motif is the MIF4G/HEAT
repeat domain that forms a protein–protein interaction surface. The markers reflect the sizes of the Prestain Protein Ladder (Euromedex).
ficiencies (Figure 5C). These data were verified by western
blot analysis forDed1. As a positive control, we verified that
the eIF4G fragments containing the eIF4E-binding motif
(amino acids 1–596) and the eIF4A site (542–952) retained
eIF4E and eIF4A, respectively (data not shown). In addi-
tion, Ded1 bound to IgG-protein A Sepharose beads was
able to retain the carboxyl-terminal eIF4G1 fragment 387–
952 (Figure 5C). The results indicated that the carboxyl-
terminal region of eIF4G1 had a higher affinity for Ded1
than the amino-terminal half. In contrast, Ded1 had lit-
tle or no affinity for the eIF4G9 fragment (160–492) that
contained only the Pab1 and eIF4E-binding sites (data not
shown). Thus, in accordance with the previously published
results, we found that fragments containing the RNA3 mo-
tif formed the strongest interactions, but that there were
other regions of eIF4G1 that interacted with Ded1 as well.
The same results were obtained when the pull-down ex-
periments were done in the presence or absence of RNase I,
which indicated that the interactions were probably not me-
diated by contaminating RNAs. Likewise, the interactions
were not affected by the presence of AMP-PNP, which is a
nonhydrolyzable analog of ATP that greatly enhances the
affinity of Ded1 for RNAs (71). Thus, the interactions were
mediated through direct protein–protein contacts, and they
were not dependent on the enzymatic activity of Ded1 per
se.
Cap-associated factors enhanced the RNA-dependent AT-
Pase activity of Ded1
The preceding experiments demonstrated thatDed1 formed
interactions with cap-associated factors, but not with con-
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trol proteins. Nevertheless, these results did not demon-
strate a functional association between the different pro-
teins. Therefore, we measured the RNA-dependent ATPase
activity ofDed1 in the presence of the different purified pro-
teins. To facilitate the analyses, we measured the reaction
rates with saturating concentrations of whole yeast RNA
and 1 mM ATP. The results are shown in Table 1, where
25-fold molar excesses of the indicated proteins were added
to the Ded1 reactions. All of the cap-associated factors en-
hanced the ATPase activity of Ded1 except for eIF4E and
Cbp20. Moreover, eIF4A had no significant effect (data
not shown); eIF4A is a DEAD-box protein with an RNA-
dependent ATPase activity, but it had<1% of the activity of
Ded1 under these conditions (4). None of the other tested
proteins showed significant ATPase activities in the absence
of Ded1. This indicated that the preparations were free of
contaminating NTPases.
We obtained good activation of Ded1 with Gle1 that was
independent of added phytic acid. Gle1 in the presence of
phytic acid is known to activate the intrinsically poor AT-
Pase activity of the DEAD-box protein Dbp5 that is in-
volved in mRNA export from the nucleus [reviewed by (6)].
However, and in contrast to our data, previously published
results indicated thatGle1 actually inhibited theATPase ac-
tivity of Ded1, and that it functioned as a negative regula-
tor of Ded1 activity (75). We have no explanation for these
contradictory results. Regardless, the interactions between
Gle1 and Ded1 were not the same as those with Dbp5 be-
cause the latter interactions are mediated directly through
phytic acid (81).
The results were consistent with Ded1 physically and
functionally interacting with the cap-associated factors, but
with some unexpected effects. The cap-binding proteins
eIF4E and Cbp20 had no effect on the activity, even though
they physically interactedwithDed1 in vitro. The amino ter-
minus of eIF4G1 (1–596) activated Ded1 better than the
carboxyl terminus (542–952), even though the latter had
a higher binding affinity. Of the individual proteins, the
amino-terminal sequences of eIF4G1 and Cbp80 (1–556)
both gave the best––and similar––stimulation, which indi-
cated that these regions were functionally the most impor-
tant. Both Pab1 and Nab2 had weak, but significant, stim-
ulatory effects.
The stimulation of the ATPase activity was cumulative,
but not additive, when different combinations of the pro-
teins were used. The eIF4F complex of proteins with Pab1
and the CBC complex (Cbp20 + Cbp80) activated Ded1
the most. This implied that Ded1 assembled on the 7-
methylguanosine of RNAswith these factors.We tested this
by using a ∼200 nucleotide-long RNA (Cyc1) that we tran-
scribed in vitro, polyadenylated and capped (7G-Cyc1-A).
We estimated that on average ∼120–150 adenosines were
added. The ATPase activation of both the unmodified Cyc1
and the modified 7G-Cyc1-A RNAs were then tested at
equal molar concentrations with various combinations of
the purified proteins. The Cyc1 RNA at 320 nM (0.020
g/l) stimulated the ATPase activity of Ded1 50% more
than saturating concentrations of whole yeast RNA (0.45
g/l), which indicated that the latter substrate contained
inhibitors as well as unproductive RNAs. The 7G-Cyc1-A
RNA typically gave slightly better activation of Ded1 than
Cyc1, but we attributed this to its larger size (320 nM was
equivalent to 0.031 g/l). Regardless, no significant dif-
ferences in activation were observed when the various co-
factors were added. Thus, the activation of Ded1 by the
cofactors was through protein–protein interactions rather
than by facilitating the assembly of Ded1 on the RNA sub-
strates. This was consistent with the observations of others
that eIF4G1 forms contacts withDed1 that are independent
of the RNA (66).
The activation was highly dependent on the quantity of
added protein; stoichiometric quantities showed weak acti-
vation that generally increased linearly with added protein
up to the 75-fold excess that was tested. The large molar
excesses needed to obtain moderate activation of Ded1 in-
dicated that the cofactors were probably not functioning as
enzymatic activators per se, as occurs with Dbp5 and Gle1.
Instead, it appeared that the cofactors were functioning
like molecular chaperones to stabilize or facilitate confor-
mations of Ded1 that were more active. Indeed, less active
preparations of Ded1 showed proportionally even larger ef-
fects for the added proteins, but they did not increase the re-
action velocities beyond those measured with the more ac-
tive Ded1 preparations. Thus, the cofactors may associate
with Ded1 and function as allosteric activators. We con-
cluded that the physical associations between Ded1 and the
cap-associated factors were biologically significant.
Ded1 was primarily associated with stable mRNPs not ac-
tively undergoing translation
Ded1 has been proposed to associate with the 43S ribo-
some late during its assembly on the eIF4F translation-
initiation complex, but prior to ribosome scanning to the
AUG start codon, and to promote subsequent formation
of the 48S ribosome [see (76) and references therein]. Ded1
is thought to enhance scanning of mRNAs and particularly
those with long, structured, 5′ UTRs. Our results suggested
that Ded1 associated with cap complexes on mRNAs very
early and perhaps even before transcriptionwas terminated.
To help clarify this apparent contradiction, we undertook
polysome analyses of yeast cells growing in early exponen-
tial phase (OD595 ∼0.8). Extracts were loaded on sucrose
gradients and the complexes separated by centrifugation.
Fractions were collected across the gradients, the recovered
proteins separated by SDS polyacrylamide electrophoresis
and then the gel was subjected to western blot analysis with
IgGs against various proteins (Figure 6; Supplemental Fig-
ure S6A).
We detected all the proteins throughout the gradients
with the exception of Cbp20, which showed no detectable
signal in the 80S or polysome region. However, the vast ma-
jority of the signals were found close to the top of the gra-
dients, which indicated that they were not actively engaged
in translation. Based on the amount of Ded1 in the load-
ing extract, we recover the vast majority of Ded1 in these
fractions (>80–90%). The peak intensities for most of the
proteins coincided. The peak for eIF4G1 also corresponded
to the other proteins, but the western blot showed multiple
fragments, which indicated that it was degraded during the
analyses. Ded1 is thought to associate with anotherDEAD-
box protein, Dhh1, in cells under conditions of stress or af-
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Table 1. In vitro ATPase activity of Ded1
Proteinsa ATPaseb % Ded1
Ded1 76.2 ± 4.9 100
+ eIF4E 79.5 ± 4.1 105
+ eIF4G (1–596) 157. ± 5. 206
+ eIF4G (542–952) 107. ± 2. 141
+ Pab1 90.4 ± 2. 119
+ eIF4E + eIF4G (1–596) 159. ± 6. 209
+ eIF4E + eIF4G (542–952) 121. ± 5. 160
+ eIF4E + eIF4G (1–596; 542–952) 172. ± 1. 227
+ eIF4F + Pab1 192. ± 5 252
+ Cpb20 74.2 ± 1.6 97
+ Cbp80 (1–556) 168. ± 6. 220
+ Cbp80 (557–861) 110. ± 5. 144
+ Nab2 115. ± 6. 150
+ Cbp20 + Cbp80 (1–556) 180. ± 10. 237
+ Cbp20 + Cbp80 (557–861) 118. ± 6. 155
+ Gle1 145. ± 11. 191
aDed1 was tested alone or with a 25-fold molar excess of the indicated proteins. The eIF4F complex consists of eIF4A, eIF4E, eIF4G (1–596 + 542–952).
bReaction velocity of the RNA-dependent ATPase activity of Ded1 using 1 mMATP shown in nM free phosphate produced per minute per nM of Ded1.
Whole yeast RNA was used at 0.45 g/l.
ter post-diauxic shift (22,74,82). Dhh1 is involved in trans-
lational repression and mRNA decay (83). We found that
under our conditions thatDhh1 sedimented at the same size
range as for the other factors. In contrast, the peak forDed1
was reproducibly shifted toward larger complexes in a re-
gion of the gradient that contained relatively little protein
(Figure 6, Supplemental Figure S6). Thus, Ded1 appeared
to be associated with a subset of the RNPs.
It is known that the pre-initiation complexes are not
completely resistant to the conditions used to extract the
cells and run the gradients (84). Therefore, it was possible
that the proteins profiles we obtained were a result of the
partial dissociation of larger complexes. We tested this for
Ded1 by analyzing polysome profiles of cells first treated,
in vivo, with formaldehyde to stabilize the complexes. Un-
der these conditions, we did see more Ded1 associated with
the polysomes and a slight peak around the 40S ribosome,
but the majority of the Ded1 migrated as before (data not
shown). Thus, we concluded that the observed complexes
with Ded1 were only partially the result of the dissociation
of larger complexes. In contrast, the majority of the other
factors sedimented in a region of the gradient that con-
tained a large amount of proteins (Figure 6). Only eIF4E
showed a slight peak in the 80S region of the gradient, which
was consistent with its role as a cap-binding protein. The
translation-initiation factor eIF4A is thought to dissoci-
ate from the mRNA prior to 80S assembly (76), and it is
not associated with the polysomes. Likewise, the CBC and
Dhh1 proteins were not expected to cosediment with trans-
lating ribosome. Thus, and in contrast to Ded1, we could
not demonstrate that a majority of these factors were asso-
ciated with stable RNPs.
It was possible that Ded1 transiently associated withmR-
NAs during the early phases of translation initiation that
preceded 40S assembly on the mRNA, as previously pro-
posed (66). Therefore, we repeated the polysome analy-
sis but with cells first treated with rapamycin. Rapamycin
blocks the TOR1-dependent signaling pathways, which
subsequently inhibits a number of cellular processes that
include translation initiation [reviewed by (85)]. We rea-
soned that if Ded1 interacted with the cap-associated fac-
tors during translation initiation, then rapamycin treatment
would alter the resulting complexes. Consistent with this,
rapamycin reduced the polysome profile and increased the
amount of free 40S, 60S and 80S ribosomes (Supplemental
Figure S6B). The western blots showed slightly altered pro-
files for the protein distributions, but they were consistent
with the factors being in complexes that were not associated
with active translation. Other workers have obtained simi-
lar results (74). However, it should be noted that the TOR2
pathway, which is involved in the expression of a subset of
genes, is not affected by rapamycin treatment.
To further characterize the complexes associated with
Ded1, we extracted the complexes of selected fractions with
Ded1-IgG Sepharose beads and then analyzed the recov-
ered proteins by nanoLC-MS/MS (Supplemental Figure
S7). The analyses were complicated by the low recovery of
some of the fractions, but we were able to identify 61 pro-
teins in fraction 4, 82 proteins in fraction 6 and 46 proteins
in fraction 7. Many of the identified proteins were unre-
lated to the proposed functions of Ded1, which indicated
that the purification strategy was not sufficiently stringent.
Nevertheless, 25% of the proteins in fraction 4, 52% in frac-
tion 6 and 59% in fraction 7 were associated with either
transcription, translation or with ribosomes. This was con-
sistent with Ded1 being in both nuclear and cytoplasmic
mRNPs. The Mascot score for Ded1 in fractions 4, 6 and
7 were 529.0, 413.4 and 368.2, respectively. We recovered
eIF4E in fractions 4 and 6 with Mascots scores of 52.2 and
67.1, respectively. Pab1 was recovered in all three fractions
(85.6, 385.3, 151.1). None of the other proteins identified by
western blot were identified by mass spectrometry. Hence,
the complete complexes associated with Ded1 may not have
been stable enough to resist our purification protocol or the
mass spectrometry analyses did not detect their presence.
For the latter possibility, it is known that some proteins are
recalcitrant to detection by mass spectrometry (86). Inter-
estingly, we also identified four proteins of the 26S protea-
some in fraction 7, which suggested that fraction 7 con-
tained complexes that sedimented at a size corresponding to
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Figure 6. Sucrose gradients of cell extracts. (A) Yeast extract of the BY4742
strain was separated on a 7–47% sucrose gradient as described in the text,
and ∼0.5-ml fractions were collected as indicated. The absorption profile
at 254 nm is shown. Cells were incubated with 0.1 g/ml of cycloheximide
for 10 min prior to harvesting. Most of the Ded1 sedimented in complexes
that were larger than those for the majority of the other detected proteins
(indicated as *). (B) Western blot analysis of the fractions separated on a
10% SDS PAGE. Every other fraction was loaded so that the entire profile
could be shown on a single gel. Ext, 10% of the original extract was loaded
on the gel as a reference. (C) Ponceau red stained membrane of the elec-
trophoretically transferred proteins from the SDS PAGE. MW, molecular
weight markers shown in kDa.
26S (Supplemental Figure S7). Finally, we verified the pres-
ence of polyadenylated RNAs by northern blot analyses of
the extracted fractions with a 32P-labeled (dT)25 probe (data
not shown). These data were consistent with Ded1 associ-
ating with different mRNP complexes in the nucleus and
cytoplasm, and they were consistent with Ded1 being asso-
ciated with the remodeling events of these mRNPs.
DISCUSSION
Ded1 is a cap-associated factor that shuttles between the cy-
toplasm and nucleus
Our experiments demonstrate that Ded1 is a physical and
functional component of the nuclear and cytoplasmic cap-
binding complexes. We find that Ded1 is genetically linked
Figure 7. Protein partners of Ded1. Ded1 interacts with the predomi-
nately nuclear CBC complex factors, which consists of Cbp20 and Cbp80,
and with Nab2. Ded1 also interacts with the predominately cytoplasmic
translation-initiation factors, which includes Pab1. We have no evidence
that Ded1 interacts with the DEAD-box protein eIF4A, which is part of
the translation-initiation complex eIF4F. Moreover, Ded1 interacts with
the DEAD-box protein Dhh1, which is often localized in P-bodies in the
cytoplasm. It is involved in mRNA decapping and degradation. Gle1 is
located on the cytoplasmic side of the nuclear pore, and it is involved in
the nuclear export of mRNAs. However, Gle1 also has been implicated in
regulating translation. The heavy lines represent interactions determined
by physical, genetic and enzymatic approaches, the medium line by phys-
ical and genetic approaches, and the medium dotted line by physical and
enzymatic approaches. The light dotted line indicates other potential sub-
strates. Interactions were determined by this work and the published work
of others (see text).
to various CBC and eIF4F proteins, and that it physically
interacts with these proteins in vitro (Figure 7). Moreover,
we find that these proteins enhance the RNA-dependent
ATPase activity of Ded1 in vitro. The Ded1-GFP protein
actively shuttles between the nucleus and cytoplasm using
both the Crm1- andMex67-dependent nuclear export path-
ways, which is largely independent of the enzymatic activ-
ity of Ded1. Thus, Ded1 is probably a component of RNPs
located both in the nucleus and the cytoplasm. Our mass
spectrometry analyses indicate that Ded1 is associated with
a large number of other proteins in cell extracts and thus in
multiple different RNPs. Finally, sucrose gradients reveal
that Ded1 cosediments with known cap-associated factors
but that the peak concentrations of the factors do not co-
incide, which indicates that Ded1 interacts with a subset
of these factors that form larger complexes. This distribu-
tion is not profoundly affected with rapamycin treatment,
which indicates that the majority of the RNPs associated
with Ded1 are not actively being translated.
These results are consistent with previous observations
that Ded1 is linked with processing events that extend from
transcription, splicing and translation to RNA degradation
(16–19,22). They also are consistent with crosslinking ex-
periments that demonstrate a physical interaction between
Ded1 and RNA polymerase II in vivo (87). And they are
consistent with microarray experiments, which compared
mRNA and pre-mRNAs levels, which implicate Ded1 as
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a spliceosome factor that influences splicing (88). Similar
results were obtained for DDX3X (68,69). Although we
limited our studies to cells growing under optimal con-
ditions (exponential growth), other workers have demon-
strated that Ded1 is found in specialized cytoplasmic gran-
ules of aggregated, translationally-inactive, mRNPs, known
as P-bodies and stress granules, under conditions of stress
(22,66,74,82).
Ded1 is associated withmRNPs that undergomultiple remod-
eling events
Cap-associated complexes are important mediators in the
control of gene expression [reviewed by (9,67)]. The 7-
methyl guanosine cap is added to the 5′ ends of pre-mRNAs
cotranscriptionally when the nascent RNAs are 22–25 nu-
cleotides long. The cap-binding proteins Cbp20 and Cbp80
associate with the RNAs shortly thereafter and remain as-
sociated with the RNAs during the different processing
events that include splicing, polyadenylation, quality con-
trol and RNA export. In mammalian cells, the CBC pro-
teins are still associated with the mRNAs during the pi-
oneering round of translation in the cytoplasm as part of
the quality control processing of the mRNAs [reviewed by
(89)]. Yeast differs from the mammalian systems in some re-
spects (e.g. there is no EJC), but the exported, CBC bound,
mRNPs also are thought to undergo a pioneering round of
translation (90). Subsequently, the various nuclear factors
are replaced by the cytoplasmic equivalents, and the eIF4F-
associated mRNAs undergo steady-state rounds of transla-
tion. At the end of their life spans, themRNAs are deadeny-
lated, the eIF4F complex dissociated, the cap removed and
the resulting RNA degraded by exonucleases, which often
occurs in the P-bodies [reviewed by (91)].
Each of the described processing events involves signif-
icant remodeling of the mRNPs. Our results, and the re-
sults of others, indicate thatDed1 is associated withmany, if
not all, of these different mRNP complexes. However, these
experiments do not distinguish between active or passive
role(s) for Ded1 nor do they reveal whether Ded1 remains
fixed to each mRNP throughout its life span. It is possi-
ble that Ded1 dissociates and then reassociates with the
mRNPs during the different remodeling events in the differ-
ent cellular compartments. This latter possibility is consis-
tent with the proposed role of Ded1 as a regulator of trans-
lation initiation (20,22,66,75). Nevertheless, we have not yet
been able to demonstrate a direct enzymatic role for Ded1
in the formation of these RNPs.
Ded1 homologs in other organisms regulate gene expression
We have shown that mouse PL10 and human DDX3X are
able to complement a deletion of Ded1 in yeast fairly well
while Belle and Vasa showmore limited effects. Others have
shown that S. pombe Ded1 also will support growth in S.
cerevisiae (52). The S. pombe Ded1 is implicated in cell cy-
cle regulation (52,92). It was shown to interact with the pro-
tein kinase Chk1, which is involved in checkpoint response,
and with the cyclin-dependent kinase Cdc2, which is in-
volved in regulating the cell cycle (93). DDX3X has multi-
ple functions in gene regulation, cell cycle control and viral
replication [reviewed by (26,94)]. More recently, DDX3X
was shown to regulate cell growth by controlling transla-
tion of cyclin E1 (95) and as a regulatory subunit of casein
kinase 1 in Wnt--catenin signaling (96). Interestingly, the
latter function was independent of the enzymatic activity of
DDX3X. DDX3X also was found to bind eIF4E and act
as a negative inhibitor of translation by preventing eIF4E
from interacting with eIF4G in a manner analogous to the
antagonistic roles of the 4E-BP proteins (97). Moreover,
DDX3X enhanced the affinity of eIF4E for the cap. This
interaction is likewise independent of the enzymatic activ-
ity of DDX3X. These results are contrary to those previ-
ously determined for Ded1 because Ded1 stimulates eIF4E-
dependent translation; eIF4E is inhibited by p20, which is
the yeast equivalent of the 4E-BP proteins (19). By these
criteria, Ded1 would be a positive regulator of translation,
while DDX3X is a negative regulator. However, other ex-
periments show a stimulatory role of DDX3X in translation
while Ded1 can be inhibitory (65,66). Moreover, DDX3X
can substitute for eIF4E under certain conditions, although
we have no evidence that this is true for Ded1 as well (98).
As seen for Ded1, DDX3X is found in stress granules
under conditions of stress. DDX3X is thought to promote
stress granule formation through its interactionswith eIF4E
and Pabp1 (99). Others have used confocal microscopy to
show that DDX3X is associated with various translation-
initiation factors in stress granules (65). DDX3X is ineffec-
tual at promoting scanning of 5′ UTRs in in vitro recon-
stitution experiments in contrast to Ded1, which enhances
the scanning of mRNAs with moderately stable basepaired
stems (100). Finally, DDX3X is thought to promote the
translation of specific mRNAs with structured 5′ UTRs,
where it binds the mRNA and clamps the entry of eIF4F
through its interactions with eIF4G and Pabp1 (65). These
interactions are only needed in the very early steps of ri-
bosome binding and prior to 43S ribosomal scanning. This
latter result points to a role for DDX3X in RNP assembly
rather than as a processive helicase to disrupt RNA sec-
ondary structures that would impede ribosomal scanning.
On the whole, these data are consistent with the Ded1 sub-
family of proteins being needed to positively or negatively
regulate the expression of specific genes that are used to con-
trol the cellular response to growth conditions and the cell
cycle.
What is the role of Ded1 in yeast?
Ded1 was originally considered as a general translation-
initiation factor that was needed to promote 43S ribosome
scanning by disrupting RNA secondary structures in the
5′ UTRs (18,19). Later work indicated that Ded1 associ-
ated with the 43S ribosome late during translation initi-
ation to promote scanning of mRNAs with long, struc-
tured, 5′ UTRs and formation of the 48S ribosome (20,76).
Ded1 has been considered a bifunctional protein that en-
hances translation initiation but at the same time can re-
press translation by promoting the sequestering of mRNPs
in P-bodies––a process that, like for DDX3X, is indepen-
dent of the ATPase activity of Ded1 (22,82). Others have
found that Ded1 interacts early with eIF4G to assemble the
mRNP translation-initiation complex, which accumulates
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in stress granules (66). Thereby, Ded1 can function as a re-
pressor of translation by forming mRNPs stalled in trans-
lation initiation and as an activator by releasing the stalled
mRNPs from the stress granules in anATP-dependent fash-
ion. Finally, Gle1 was found, in contrast with our results,
to be a negative regulator of Ded1 in translation initiation
through direct protein–protein interactions (75). Neverthe-
less, Ded1 has been implicated in transcription and splicing
as well (16,17,87,88).
Our experiments indicate that Ded1 associates with the
cap complexes of a subset of mRNPs very early in the
life of the mRNAs in the nucleus, and that these mRNPs
are subsequently exported to the cytoplasm. However, we
cannot be sure of the role that Ded1 plays in these differ-
ent complexes or even if Ded1 remains associated with the
same mRNA throughout the processing events. It is pos-
sible that Ded1 is needed to provide the energy necessary
to drive the remodeling of the different RNPs. For exam-
ple, Cbp20 binds the cap structures of mRNAs with up to
40-fold higher affinity than eIF4E (101). Thus, the remodel-
ing of the CBC complex into the eIF4F initiation complex
would require a substantial amount of energy that could
be provided through the ATPase activity of Ded1. Like-
wise, energy would be required to drive the other remodel-
ing events to completion in a unidirectional fashion. How-
ever, there are other NTP-dependent DExD/H-box pro-
teins implicated in these processes as well, so we cannot
attribute a specific role for Ded1. Nevertheless, our exper-
iments, and the experiments of others, strongly support a
role of Ded1 in the regulation of gene expression of a sub-
set of proteins that are probably involved in controlling the
cellular response to the growth conditions and in regulat-
ing the cell cycle. Ded1 may associate with specific mRNAs
linked with these proteins and mark them for processing,
export, translation, storage or degradation. Ded1may drive
the remodeling events of the mRNPs needed to express the
genetic information or alternatively itmay become activated
by the remodeling events to promote, for example, the for-
mation of the translation-initiation complex. Additional ex-
perimentation is needed to clarify all this, but it appears
clear that Ded1 serves an important role or roles very early
in the lifespan of the mRNAs.
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